Fibrobiologics, INC. (FBLG) SEC Filings — 2025
21 SEC filings for Fibrobiologics, INC. (FBLG) in 2025.
Filings
- FibroBiologics Seeks Reverse Split, Share Issuance Approvals — DEF 14A · Dec 29, 2025
- FibroBiologics Registers 22.5M Shares for Resale, Eyes $7.5M from Warrants — S-1 · Dec 23, 2025
- FibroBiologics Seeks Reverse Split, Massive Share Issuances — DEF 14A · Dec 18, 2025
- FibroBiologics Files 8-K: Material Agreement, Equity Sales — 8-K · Dec 15, 2025
- Fibrobiologics, INC. 8-K Filing — 8-K · Nov 25, 2025
- Fibrobiologics, INC. 8-K Filing — 8-K · Nov 19, 2025
- FibroBiologics' Losses Double Amid Soaring R&D, Cash Dwindles — 10-Q · Oct 31, 2025
- FibroBiologics Faces Delisting Concerns — 8-K · Aug 8, 2025
- FibroBiologics Posts Zero Revenue, Deepens Losses Amid Equity Raises — 10-Q · Jul 31, 2025
- FibroBiologics Reports Unregistered Equity Sales — 8-K · Jul 18, 2025
- FibroBiologics Faces Listing Rule Issues — 8-K · Jul 3, 2025
- FibroBiologics Files 8-K: Agreements, Obligations, Equity Sales — 8-K · Jun 16, 2025
- FibroBiologics Files 8-K on Shareholder Votes & Bylaws — 8-K · Jun 13, 2025
- FibroBiologics Appoints New CMO, Adds Directors — 8-K · Jun 9, 2025
- FibroBiologics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- FibroBiologics Appoints New CEO, Adds Director, Restructures Executive Roles — 8-K · May 5, 2025
- FibroBiologics Files 2024 Proxy Statement — DEF 14A · Apr 23, 2025
- FibroBiologics Files 2024 10-K — 10-K · Mar 31, 2025
- FibroBiologics Files 8-K on Equity Sales — 8-K · Feb 7, 2025
- FibroBiologics Appoints New CMO, Adds Director — 8-K · Jan 24, 2025
- FibroBiologics Files S-1/A for IPO — S-1/A · Jan 10, 2025